logo

Pds Biotechnology Corp (PDSB)



Trade PDSB now with
  Date
  Headline
4/8/2022 8:04:28 AM PDS Biotechnology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/2/2022 8:10:54 AM PDS Biotechnology: VERSATILE-002 2 Study For Advanced HPV-associated Head And Neck Cancer Meets Preliminary Objective
10/4/2021 8:39:50 AM PDS Biotech Enrolls First Stage Of Patient Of Phase 2 Clinical Trial In Advanced HPV-16 Positive Head And Neck Cancer
9/9/2021 8:44:03 AM PDS Biotech Completes Enrollment Of Lead-In Safety Cohort In VERSATILE-002 Phase 2 Combination Trial Of PDS0101-KEYTRUDA
9/9/2021 8:37:48 AM PDS Biotech Completes Enrollment Of VERSATILE-002 Phase 2 Combination Trial Of PDS0101-KEYTRUDA
6/8/2021 6:07:06 AM PDS Biotechnology Announces Presentation Of Interim Data From Phase 2 Trial At ASCO
6/3/2021 8:59:19 AM PDS Biotechnology Announces Protocol Amendment To Expand Its Phase 2 VERSATILE-002 Study